All Blog Posts Tagged 'marketing' (14)

The international agreement to assemble all Quality, Safety and Efficacy information for a drug or biologic product into a common format (called the CTD - Common Technical Document) has improved the speed and efficiency for companies working in global development programs and clarified expectations by regulatory bodies.  Reformatting for multiple submissions is substantially limited.  The CTD has improved the regulatory review processes and enabled implementation of good review…

Continue

If you go "off label" with advertising and promotion, FDA's hammer can hit hard and seemingly out of the blue. Advertising and promotion for devices is weak and lacks legal clarity. For drugs, the regulations are prescriptive and guidance documents clamp down on nuances. Marketing and regulatory affairs departments must collaborate to avoid the hammer and penalties of FDA. The roadblock, however is that marketing managers and regulatory affairs managers rarely reach common ground and are…

Continue

Continue

Continue

Continue

Continue

Any company or individual that is required to submit IRS Form 1099 can avail a facility the Internal Revenue Service (IRS) has: the Taxpayer Identification Number (TIN) matching. This matching or likeness is among an assortment of e-services that gives what are called “authorized payers” the opportunity to match and state their own 1099 payee information with the pertinent records from the IRS. The TIN matching is a pre-filing facility, since it is done before an entity files information…

Continue

The in-vitro diagnostics (IVD) market is a diverse and fast changing one. Of late, one of the significant changes that happened to it resulted from the passage of the Final Rule. As part of the Affordable Care Act (ACA) or Obamacare, the Centers for Medicare and Medicaid Services (CMS) introduced the Final Rule to the 2014 Protecting Access to Medicare Act (PAMA) in mid-2016, which is set to make a significant impact on the in-vitro diagnostics market by delaying implementation of…

Continue

Colleagues,



In the continuing quest to bring you the 3C's of "Content, Community & Collaboration" please see our latest list of recommended books.



For your convenience, you can order a selection directly, if you choose, thru The "MedTech-IQ" Recommended Reading Center carousel. The book carousel is located on the "MedTech-IQ" homepage, just under "Latest… Continue

Colleagues,



Thank you to MedTech-IQ member, Adrian, for this posting ...



Please contact me (click my link to follow) if you, or a referral you would like to make, is interested. My link is: CC...Conrad Clyburn (Clymer… Continue

Thinking Pharma is delighted to Welcome it’s new SEVP of Thinking Pharma – Sally Church.

Dr Sally is an eminent Blogger and Marketeer. Sally’s own enterprise, Icarus Consultants, will continue as we complete the transition into Thinking Pharma in the mean time enjoy Sally’s Thoughtware.





“Anyone can herd cattle” is like saying, “Anyone can go through the motions of a… Continue

Colleagues,



Interesting guest blog from Roberta Rochman, RN, MBA in Examiner.Com on the spreading use of Health 2.0 tools by top flight medical institutions such as Johns Hopkins, Mayo Clinic and Duke University...



ENJOY!



CC

------------------------------------------------------------------------------------

Yes, indeed, 297 hospitals use some form of Social… Continue

Jon Richman has done a fine column in Advertising Age about the future of digital marketing for pharma. He is drawn into five major predictions

1. Patients will have a portable network tool showing recommendations from trusted friends

2. Service companies who match patients with similar conditions to each other using opt-ins from electronic medical records

3. Pharma will abandon their own websites… Continue